Orphans and Incentives

Orphans and Incentives PDF Author: Forum on Emerging Infections
Publisher: National Academies Press
ISBN: 0309591333
Category : Medical
Languages : en
Pages : 113

Get Book

Book Description
Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over time, owing to HIV/AIDS, pneumonia, and septicemia, with drug resistance playing an ever-increasing role in each of these disease categories. This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with other demands for investment. Vaccines are quintessential examples of such products. The lessons learned fall into four areas, including what makes intersectoral collaboration a reality, the notion of a product life cycle, the implications of divergent sectoral mandates and concepts of risk, and the roles of advocacy and public education. The summary contains an examination of the Children's Vaccine Initiative and other models, an industry perspective on the emerging infections agenda, and legal and regulatory issues.

Orphans and Incentives

Orphans and Incentives PDF Author: Forum on Emerging Infections
Publisher: National Academies Press
ISBN: 0309591333
Category : Medical
Languages : en
Pages : 113

Get Book

Book Description
Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over time, owing to HIV/AIDS, pneumonia, and septicemia, with drug resistance playing an ever-increasing role in each of these disease categories. This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with other demands for investment. Vaccines are quintessential examples of such products. The lessons learned fall into four areas, including what makes intersectoral collaboration a reality, the notion of a product life cycle, the implications of divergent sectoral mandates and concepts of risk, and the roles of advocacy and public education. The summary contains an examination of the Children's Vaccine Initiative and other models, an industry perspective on the emerging infections agenda, and legal and regulatory issues.

Orphans and Incentives

Orphans and Incentives PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309059410
Category : Medical
Languages : en
Pages : 113

Get Book

Book Description
Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over time, owing to HIV/AIDS, pneumonia, and septicemia, with drug resistance playing an ever-increasing role in each of these disease categories. This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with other demands for investment. Vaccines are quintessential examples of such products. The lessons learned fall into four areas, including what makes intersectoral collaboration a reality, the notion of a product life cycle, the implications of divergent sectoral mandates and concepts of risk, and the roles of advocacy and public education. The summary contains an examination of the Children's Vaccine Initiative and other models, an industry perspective on the emerging infections agenda, and legal and regulatory issues.

Rare Diseases and Orphan Products

Rare Diseases and Orphan Products PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442

Get Book

Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.

Economic Incentives for Children and Families to Eliminate Or Reduce Child Labour

Economic Incentives for Children and Families to Eliminate Or Reduce Child Labour PDF Author: Richard Anker
Publisher:
ISBN:
Category : Child labor
Languages : en
Pages : 76

Get Book

Book Description


The Perfect Orphans Laws and Their Rights to Their Own Property. Extracts from the Book of Creation

The Perfect Orphans Laws and Their Rights to Their Own Property. Extracts from the Book of Creation PDF Author: David Gomadza
Publisher: David Gomadza
ISBN:
Category : Business & Economics
Languages : en
Pages : 59

Get Book

Book Description
The Perfect Orphans Laws and Their Rights to Their Own Property. Extracts from the Book of Creation. Extracts from the Book of Creation

Orphan Drug Amendments of 1991

Orphan Drug Amendments of 1991 PDF Author: United States. Congress. Senate. Committee on Labor and Human Resources
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 192

Get Book

Book Description


The Value of Praise and Reproof as Incentives for Children

The Value of Praise and Reproof as Incentives for Children PDF Author: Elizabeth Bergner Hurlock
Publisher:
ISBN:
Category : Child development
Languages : en
Pages : 92

Get Book

Book Description


Child Welfare

Child Welfare PDF Author: Emilie Stoltzfus
Publisher: CreateSpace
ISBN: 9781490957852
Category : Law
Languages : en
Pages : 48

Get Book

Book Description
Under the Adoption Incentives program states earn federal bonuses when they increase adoptions of children who are in need of new permanent families. All 50 states, the District of Columbia, and Puerto Rico have earned a part of the $375 million in Adoption Incentive funds that have been awarded since the program was established as part of the Adoption and Safe Families Act of 1997. Funding authorized for this program has been extended twice since it was established, most recently in 2008, but is currently set to expire on September 30, 2013. Since ASFA's enactment in 1997, the annual number of children leaving foster care for adoption has risen from roughly 30,000 to more than 50,000 and the average length of time it took states to complete the adoption of a child from foster care declined by close to one year (from about four years to less than three). Over the same time period, and in significant measure due to the greater number of children leaving foster care for adoption and at a faster pace, the overall number of children who remain in foster care declined by 29%. Despite these successes, however, the number of children “waiting for adoption” remains more than double the number of children who are adopted during a given year. Under the current Adoption Incentive bonus structure, states earn $4,000 for each adoption of a foster child that is above the number of foster child adoptions finalized by the state in FY2007 and $8,000 for each adoption of an older child (9 years or older) above the number of older child adoptions it finalized in FY2007. If a state has earned an award in either of those categories—or if it improves its adoption rate—it earns $4,000 for each adoption of a special needs child (under age 9) that is above the number of such adoptions it finalized in FY2007. For improving its rate of adoption, a state is eligible for additional incentive funds of $1,000 multiplied by the increased number of adoptions that are calculated to have resulted from the improved adoption rate. However, increases in incentive amounts states earn due to improved adoption rates are only paid to those states if sufficient program appropriations are available after all awards for increases in the number of adoptions have been made. States are permitted to use Adoption Incentive bonuses to support a broad range of child welfare services to children and families. Many states report spending incentive funds on adoption-related child welfare purposes, including post-adoption support services, recruitment of adoptive homes, and training or conferences to improve adoption casework. A smaller number of states report using these funds for adoption assistance payments, improved adoption homes studies, child protection casework, foster care maintenance payments, or other child welfare purposes. Funding for the Adoption Incentives program is provided on a discretionary basis as part of the annual appropriations process. The program is authorized to receive $43 million annually (through FY2013), but in recent years actual appropriations have been around $39 million. Final FY2013 appropriations for the Adoption Incentives program were included in the Consolidated and Further Continuing Appropriations Act, 2013 at this same level. However, those appropriations are subject to a 5% reduction (under the March 1 sequestration order).

Pediatric Neurology, Part I

Pediatric Neurology, Part I PDF Author: Olivier Dulac
Publisher: Newnes
ISBN: 0444626980
Category : Medical
Languages : en
Pages : 893

Get Book

Book Description
The child is neither an adult miniature nor an immature human being: at each age, it expresses specific abilities that optimize adaptation to its environment and development of new acquisitions. Diseases in children cover all specialties encountered in adulthood, and neurology involves a particularly large area, ranging from the brain to the striated muscle, the generation and functioning of which require half the genes of the whole genome and a majority of mitochondrial ones. Human being nervous system is sensitive to prenatal aggression, is particularly immature at birth and development may be affected by a whole range of age-dependent disorders distinct from those that occur in adults. Even diseases more often encountered in adulthood than childhood may have specific expression in the developing nervous system. The course of chronic neurological diseases beginning before adolescence remains distinct from that of adult pathology – not only from the cognitive but also motor perspective, right into adulthood, and a whole area is developing for adult neurologists to care for these children with persisting neurological diseases when they become adults. Just as pediatric neurology evolved as an identified specialty as the volume and complexity of data became too much for the general pediatician or the adult neurologist to master, the discipline has now continued to evolve into so many subspecialties, such as epilepsy, neuromuscular disease, stroke, malformations, neonatal neurology, metabolic diseases, etc., that the general pediatric neurologist no longer can reasonably possess in-depth expertise in all areas, particularly in dealing with complex cases. Subspecialty expertise thus is provided to some trainees through fellowship programmes following a general pediatric neurology residency and many of these fellowships include training in research. Since the infectious context, the genetic background and medical practice vary throughout the world, this diversity needs to be represented in a pediatric neurology textbook. Taken together, and although brain malformations (H. Sarnat & P. Curatolo, 2007) and oncology (W. Grisold & R. Soffietti) are covered in detail in other volumes of the same series and therefore only briefly addressed here, these considerations justify the number of volumes, and the number of authors who contributed from all over the world. Experts in the different subspecialties also contributed to design the general framework and contents of the book. Special emphasis is given to the developmental aspect, and normal development is reminded whenever needed – brain, muscle and the immune system. The course of chronic diseases into adulthood and ethical issues specific to the developing nervous system are also addressed. A volume in the Handbook of Clinical Neurology series, which has an unparalleled reputation as the world's most comprehensive source of information in neurology International list of contributors including the leading workers in the field Describes the advances which have occurred in clinical neurology and the neurosciences, their impact on the understanding of neurological disorders and on patient care

South Africa Pushed to the Limit

South Africa Pushed to the Limit PDF Author: Hein Marais
Publisher: Bloomsbury Publishing
ISBN: 1780320833
Category : Political Science
Languages : en
Pages : 624

Get Book

Book Description
Since 1994, the democratic government in South Africa has worked hard at improving the lives of the black majority, yet close to half the population lives in poverty, jobs are scarce, and the country is more unequal than ever. For millions, the colour of people's skin still decides their destiny. In his wide-ranging, incisive and provocative analysis, Hein Marais shows that although the legacies of apartheid and colonialism weigh heavy, many of the strategic choices made since the early 1990s have compounded those handicaps. Marais explains why those choices were made, where they went awry, and why South Africa's vaunted formations of the left -- old and new -- have failed to prevent or alter them. From the real reasons behind President Jacob Zuma's rise and the purging of his predecessor, Thabo Mbeki, to a devastating critique of the country's continuing AIDS crisis, its economic path and its approach to the rights and entitlements of citizens, South Africa Pushed to the Limit presents a riveting benchmark analysis of the incomplete journey beyond apartheid.